A New Pathway in Colorectal Cancer Cells Triggered by Drug-Activated Mutant KRAS
Oncogenic mutations of KRAS are associated with a host of human malignancies, in particular, pancreatic, colorectal and lung cancer. Therefore, there is heightened interest in the design and development of […]